Stay updated on XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.

Latest updates to the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page
- Check3 days agoChange DetectedA sitewide NIH announcement about website updates and terminology during a transition is no longer displayed.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check17 days agoChange DetectedA site-wide notice announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check24 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page now displays a 403 Forbidden message, and the previously visible study details and location information have been removed from this view.SummaryDifference18%

Stay in the know with updates to XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.